[Image: masthead]

24-HOUR MH HOTLINE

800-644-9737

FOR EMERGENCIES ONLY

24-HOUR MH HOTLINE: 800-644-9737
FOR EMERGENCIES ONLY

MHAUS Recommendations

MHAUS Recommendations

The MHAUS Recommendation Development Process

  • Research and review of a topic by an MH expert;
  • Preparation of a summary document, which includes the proposed recommendations and includes rationale and supporting evidence.
  • Review of MHAUS Professional Advisory Council and the MH Hotline Consultants;
  • Review of the document in a “public comment” period of 30 days and considered for the final recommendation.

Once the appropriate revisions are made to the recommendation document and approved by a majority of our MHAUS advisers, we will formally release it here on MHAUS.org

On topics that we are frequently asked for guidance, the following evidence-based recommendations have been developed for use in the healthcare community:

Does Noonan Syndrome Increase Malignant Hyperthermia Susceptibility?
Does Noonan Syndrome Increase Malignant Hyperthermia Susceptibility?

Recommendations and supporting evidence.

Adverse Effects of Heat and Exercise in Relation to MH Susceptibility
Adverse Effects of Heat and Exercise in Relation to MH Susceptibility

Recommendations and supporting evidence.

Does Mitochondrial Myopathy (MM) Increase an Individual's Susceptibility to Malignant Hyperthermia (MH)?
Does Mitochondrial Myopathy (MM) Increase an Individual's Susceptibility to Malignant Hyperthermia (MH)?

Recommendations and supporting evidence.

MH-Susceptibility and Operating Room Personnel: Defining the Risks
MH-Susceptibility and Operating Room Personnel: Defining the Risks

The contraindications for the administration of succinylcholine and the potent volatile inhalational anesthetics to Malignant Hyperthermia Susceptible (MHS) individuals are well documented and defined.  However, there are no published data on risks to these individuals associated with environmental exposure to waste gases in the operating room.

Parturient with MHS Partner
Parturient with MHS Partner

Suggested Guidelines for management of the Pregnant-patient not believed to be at risk for MH, but WHOSE PARTNER is susceptible to malignant hyperthermia.

Preparation of Anesthesia Workstations to Anesthetize MH Susceptible Patients
Preparation of Anesthesia Workstations to Anesthetize MH Susceptible Patients

Recommendations for the preparation of anesthesia workstations to anesthetize MH susceptible patients.

Temperature Monitoring during Surgical Procedures
Temperature Monitoring during Surgical Procedures

MHAUS recommends core temperature monitoring for all patients given general anesthesia lasting more than 30 minutes. Appropriate sites for continuous electronic core temperature monitoring include the esophagus, nasopharynx, tympanic membrane (with probe in contact with the membrane), bladder, and the pulmonary artery.

see also

The mission of MHAUS is to promote optimum care and
scientific understanding of MH and related disorders.